UNICA IRIS Institutional Research Information System

SIMOLA, NICOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 173.029
NA - Nord America 9.142
AS - Asia 3.816
SA - Sud America 610
AF - Africa 100
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 7
Totale 186.713
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 171.058
US - Stati Uniti d'America 9.017
SG - Singapore 1.482
CN - Cina 1.369
UA - Ucraina 487
BR - Brasile 485
SE - Svezia 446
VN - Vietnam 374
DE - Germania 244
FI - Finlandia 205
GB - Regno Unito 184
FR - Francia 172
HK - Hong Kong 148
IN - India 89
CA - Canada 59
KR - Corea 57
PL - Polonia 49
AR - Argentina 43
BD - Bangladesh 41
MX - Messico 36
NL - Olanda 35
IQ - Iraq 32
JP - Giappone 31
RU - Federazione Russa 29
ZA - Sudafrica 25
ID - Indonesia 23
PK - Pakistan 23
TR - Turchia 22
ES - Italia 19
CO - Colombia 18
MA - Marocco 18
BE - Belgio 16
EC - Ecuador 16
EG - Egitto 16
UZ - Uzbekistan 16
VE - Venezuela 15
AT - Austria 14
CL - Cile 13
SA - Arabia Saudita 13
CH - Svizzera 12
PH - Filippine 12
CZ - Repubblica Ceca 11
PE - Perù 10
IE - Irlanda 9
EU - Europa 8
IL - Israele 8
JO - Giordania 8
KE - Kenya 8
IR - Iran 7
MY - Malesia 7
NI - Nicaragua 7
TN - Tunisia 7
JM - Giamaica 6
KZ - Kazakistan 6
LT - Lituania 6
TW - Taiwan 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
OM - Oman 5
AZ - Azerbaigian 4
ET - Etiopia 4
NG - Nigeria 4
PA - Panama 4
PT - Portogallo 4
RO - Romania 4
TH - Thailandia 4
UY - Uruguay 4
NO - Norvegia 3
NP - Nepal 3
PS - Palestinian Territory 3
PY - Paraguay 3
RS - Serbia 3
SN - Senegal 3
TJ - Tagikistan 3
AL - Albania 2
AO - Angola 2
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
GE - Georgia 2
HR - Croazia 2
KH - Cambogia 2
KW - Kuwait 2
MN - Mongolia 2
NZ - Nuova Zelanda 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CM - Camerun 1
CY - Cipro 1
DJ - Gibuti 1
DK - Danimarca 1
DM - Dominica 1
EE - Estonia 1
GF - Guiana Francese 1
Totale 186.694
Salva come PNG Salva come JPEG
Città #
Cagliari 166.661
Uta 3.886
Fairfield 1.013
Ashburn 802
Woodbridge 732
Singapore 728
Chandler 594
Dallas 479
Houston 436
San Jose 423
Ann Arbor 396
Seattle 369
Wilmington 355
Cambridge 352
Boardman 319
Beijing 300
Nyköping 289
Jacksonville 244
New York 229
Dearborn 192
Los Angeles 129
Hong Kong 128
Santa Clara 127
Nanjing 113
Helsinki 112
Council Bluffs 109
The Dalles 107
Shanghai 105
Lauterbourg 98
Ho Chi Minh City 97
Hangzhou 93
Boston 92
Dong Ket 68
Hefei 59
Hanoi 57
Seoul 52
Buffalo 51
San Diego 50
Munich 44
Guangzhou 42
Milan 35
Shenyang 35
Frankfurt am Main 32
São Paulo 32
Toronto 32
London 30
Redondo Beach 29
Brooklyn 28
Norwalk 27
Tianjin 26
Nanchang 25
Redwood City 25
Tokyo 24
Chicago 23
Falls Church 23
Rome 23
Hebei 22
Orem 22
Sassari 20
Da Nang 19
Warsaw 19
Chennai 18
Montreal 18
Sestu 18
Changsha 17
Cracow 17
Atlanta 16
Haiphong 16
Mexico City 16
Mountain View 16
Phoenix 16
Washington 15
Brussels 14
Jinan 14
Tashkent 14
Verona 14
Amsterdam 13
Jiaxing 13
Ningbo 13
Zhengzhou 13
Curitiba 12
Dhaka 12
Orange 12
Padova 12
Columbus 11
Johannesburg 11
Lappeenranta 11
Manchester 10
New Delhi 10
Nuremberg 10
Rio de Janeiro 10
Wuhan 10
Auburn Hills 9
Baghdad 9
Belo Horizonte 9
Brasília 9
Casablanca 9
Kunming 9
Oristano 9
Porto Alegre 9
Totale 181.577
Salva come PNG Salva come JPEG
Nome #
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease 4.290
Pharmacological characterization of 50-kHz ultrasonic vocalizations in rats: comparison of the effects of different psychoactive drugs and relevance in drug-induced reward 3.642
Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease 3.544
Widespread reduction of dopamine cell bodies and terminals in adult rats exposed to a low dose regimen of MDMA during adolescence 3.480
Strain dependence of adolescent Cannabis influence on heroin reward and mesolimbic dopamine transmission in adult Lewis and Fischer 344 rats 3.374
Role of Adenosine in the basal Ganglia 3.357
The novel psychoactive substance methoxetamine induces persistent behavioral abnormalities and neurotoxicity in rats 3.169
Antagonism of Adenosine A1 or A2A Receptors Amplifies the Effects of 3,4-Methylendioxymethamphetamine (MDMA) on Glial Activation in the Mouse Brain: Relevance to Caffeine-MDMA Interactions 3.118
Dopaminergic neurodegeneration in a rat model of long-term hyperglycemia: preferential degeneration of the nigrostriatal motor pathway 3.017
Elevation of striatal urate in experimental models of Parkinson's disease: a compensatory mechanism triggered by dopaminergic nigrostriatal degeneration? 3.013
Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms 2.960
Protective Agents in Parkinson's Disease: Caffeine and Adenosine A2A Receptor Antagonists 2.937
Direct and long-lasting effects elicited by repeated drug administration on 50-kHz ultrasonic vocalizations are regulated differently: Implications for the study of the affective properties of drugs of abuse 2.849
Modulation of rat 50-kHz ultrasonic vocalizations by glucocorticoid signaling: possible relevance to reward and motivation 2.826
Role of adenosine A2A receptors in motor control: relevance to Parkinson’s disease and dyskinesia 2.778
Effect of crowding, temperature and age on glia activation and dopaminergic neurotoxicity induced by MDMA in the mouse brain 2.722
Methylxanthines and drug dependence: interactions and toxicity 2.699
Symptomatic and Neuroprotective Effects of A2A Receptor Antagonists in Parkinson’s Disease 2.685
Amphetamine usage, misuse, and addiction processes: an overview 2.638
Neuronal and peripheral damages induced by synthetic psychoactive substances: an update of recent findings from human and animal studies 2.628
Microglial and astroglial activation by 3,4-methylenedioxymethamphetamine (MDMA) in mice depends on S(+) enantiomer and is associated with an increase in body temperature and motility 2.538
Dual target strategy: combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates l-DOPA-induced rotational behavior in a rodent model of Parkinson's disease 2.525
Progression and Persistence of Neurotoxicity Induced by MDMA in Dopaminergic Regions of the Mouse Brain and Association with Noradrenergic, GABAergic, and Serotonergic Damage 2.521
Repeated Administration of 3,4-Methylenedioxymethamphetamine (MDMA) Elevates the Levels of Neuronal Nitric Oxide Synthase in the Nigrostriatal System: Possible Relevance to Neurotoxicity 2.519
Assessment of symptomatic and neuroprotective efficacy of Mucuna pruriens seed extract in rodent model of Parkinson's disease 2.512
Influence of dopamine transmission in the medial prefrontal cortex and dorsal striatum on the emission of 50-kHz ultrasonic vocalizations in rats treated with amphetamine: Effects on drug-stimulated and conditioned calls 2.507
Involvement of Glutamate NMDA Receptors in the Acute, Long-Term, and Conditioned Effects of Amphetamine on Rat 50kHz Ultrasonic Vocalizations 2.427
Activation of adenosine A2A receptors suppresses the emission of pro-social and drug-stimulated 50-kHz ultrasonic vocalizations in rats: possible relevance to reward and motivation 2.399
L-DOPA disrupts adenosine A(2A)-cannabinoid CB(1)-dopamine D(2) receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: Biochemical and behavioral studies 2.348
Gut Microbiota and Metabolome Alterations Associated with Parkinson’s Disease 2.334
MDMA administration during adolescence exacerbates MPTP-induced cognitive impairment and neuroinflammation in the hippocampus and prefrontal cortex 2.273
Contribution of Caffeine to the Psychostimulant, Neuroinflammatory and Neurotoxic Effects of Amphetamine-Related Drugs 2.204
Performance of movement in hemiparkinsonian rats influences the modifications induced by dopamine agonists in striatal efferent dynorphinergic neurons 2.121
A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug 2.106
Emission of categorized 50-kHz ultrasonic vocalizations in rats repeatedly treated with amphetamine or apomorphine: possible relevance to drug-induced modifications in the emotional state 2.105
Neurophysiological and Neurochemical Effects of the Putative Cognitive Enhancer (S)-CE-123 on Mesocorticolimbic Dopamine System 2.000
Preface [ to The Adenosinergic System. A Non-Dopaminergic Target in Parkinson’s Disease] 1.987
Repeated amphetamine administration and long-term effects on 50-kHz ultrasonic vocalizations: possible relevance to the motivational and dopamine-stimulating properties of the drug 1.984
Role of movement in long-term basal ganglia changes: implications for abnormal motor responses 1.966
Ultrasonic vocalizations as a tool in studying emotional states in rodent models of social behavior and brain disease 1.922
Alteration in the progression of dopamine neuron degeneration: May caffeine offer new perspective? 1.885
Gender Differences in Neurodegeneration, Neuroinflammation and Na+-Ca2+ Exchangers in the Female A53T Transgenic Mouse Model of Parkinson’s Disease 1.835
Increased emissions of 50-kHz ultrasonic vocalizations in hemiparkinsonian rats repeatedly treated with dopaminomimetic drugs: A potential preclinical model for studying the affective properties of dopamine replacement therapy in Parkinson's disease 1.825
Unbinding of Translocator Protein 18 kDa (TSPO) Ligands: From in Vitro Residence Time to in Vivo Efficacy via in Silico Simulations 1.818
Dyskinesia in Parkinson's disease: mechanisms and current non-pharmacological interventions 1.806
Caffeine consumption and changes in the function of dopaminergic transmission: evidence of a hyperdopaminergic state in rats subchronically treated with caffeine 1.791
Pharmacological therapy of Parkinson's disease: current options and new avenues 1.774
null 1.722
Repertoire and Biological Function of Ultrasonic Vocalizations in Adolescent and Adult Rats 1.713
Effect of long-term administration of antiretroviral drugs (Tenofovir and Nevirapine) on neuroinflammation and neuroplasticity in mouse hippocampi 1.681
null 1.651
Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat 1.649
Effects of Psychostimulants on Rat Emotional States and Emission of Ultrasonic Vocalizations 1.538
The sweet road to Parkinson's disease 1.519
Diabetes, a Contemporary Risk for Parkinson’s Disease: Epidemiological and Cellular Evidences 1.476
Ultrasonic vocalizations in rats: a tool for the investigation of psychoactive drugs and neuropsychiatric conditions 1.470
Adenosine A2A receptors: localization and function 1.469
Gender specific reduction of hypermotility by sub-chronic methylphenidate or atomoxetine in SH rats, an animal model of ADHD 1.434
Rat 50-kHz ultrasonic vocalizations as a tool in studying neurochemical mechanisms that regulate positive emotional states 1.405
Adenosine signaling in the basal ganglia 1.302
Blockade of globus pallidus adenosine A2A receptors displays antiparkinsonian activity in 6-hydroxydopamine-lesioned rats treated with D1 or D2 dopamine receptor agonists 1.292
Characterization of the antiparkinsonian effects of the new adenosine A2A receptor antagonist ST1535: acute and subchronic studies in rats 1.283
Rat ultrasonic vocalizations and behavioral neuropharmacology: from the screening of drugs to the study of disease 1.251
Acute perinatal asphyxia impairs non-spatial memory and alters motor coordination in adult male rats 1.208
Neurochemical and Behavioral Characterization after Acute and Repeated Exposure to Novel Synthetic Cannabinoid Agonist 5-MDMB-PICA 1.196
null 1.194
The 6-hydroxydopamine model of Parkinson's disease 1.186
Anti-HIV drugs promote β-amyloid deposition and impair learning and memory in BALB/c mice 1.181
Adenosine A2A receptor antagonist treatment of Parkinson’s disease 1.141
Adenosine A2A receptor antagonists and Parkinson’s disease: state of the art and future directions 1.134
In utero exposure to dexamethasone causes a persistent and age-dependent exacerbation of the neurotoxic effects and glia activation induced by MDMA in dopaminergic brain regions of C57BL/6J mice 1.130
null 1.108
A2A receptor antagonism and dyskinesia in Parkinson’s Disease 1.105
Caffeine Consumption and Changes in the Function of Dopaminergic Transmission: Evidence of a Hyperdopaminergic State in Rats Subchronically Treated with Caffeine 1.086
Perinatal asphyxia: CNS development and deficits with delayed onset 1.033
Anxyiolytic properties of a 2-phenylindolglyoxylamide TSPO ligand: Stimulation of in vitro neurosteroid production affecting GABAA receptor activity 1.027
Methylxanthines and Drug Dependence: A Focus on Interactions with Substances of Abuse 1.026
Repeated exposure to JWH-018 induces adaptive changes in the mesolimbic and mesocortical dopamine pathways, glial cells alteration and behavioural correlates 1.025
The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex 1.017
null 1.012
Activation of Antioxidant and Proteolytic Pathways in the Nigrostriatal Dopaminergic System After 3,4-Methylenedioxymethamphetamine Administration: Sex-Related Differences 990
null 967
Lack of drug- and cue-stimulated emissions of ultrasonic vocalizations in C57BL/6 J mice repeatedly treated with amphetamine 956
Protective Agents in Parkinson’s Disease: Caffeine and Adenosine A2A Receptor Antagonists 951
Perinatal asphyxia: current status and approaches towards neuroprotective strategies, with focus on sentinel proteins 924
Priming of rotational behavior by a dopamine receptor agonist in hemiparkinsonian rats: Movement-dependent induction 916
What do you see as the main priorities, Opportunities, and Challenges in Caffeine Research in the Next Five Years? 885
Effects of combination antiretroviral drugs (cART) on hippocampal neuroplasticity in female mice 871
Association between novel object recognition/spontaneous alternation behavior and emission of ultrasonic vocalizations in rats: Possible relevance to the study of memory 865
Acute and long-term effects elicited by psychoactive drugs on 50-kHz ultrasonic vocalizations in rats: development of a new experimental tool for the study of drug-mediated reward. 788
Nicotinamide prevents the long-term effects of perinatal asphyxia on apoptosis, non-spatial working memory and anxiety in rats 777
Caffeine 770
Editorial of special issue – Synthetic psychoactive substances and neurological diseases: Toxic and therapeutic effects 746
Can dietary substances protect against Parkinson's disease? The case of caffeine 730
null 685
Increase of dopamine D2(High) receptors in the striatum of rats sensitized to caffeine motor effects 642
Influence of acute caffeine on 50-kHz ultrasonic vocalizations in male adult rats and relevance to caffeine-mediated psychopharmacological effects 604
null 594
Dopaminergic Treatments for Parkinson’s Disease: Light and Shadows 586
Anxiolytic-like effects of N,N-dialkyl-2-phenylindol-3-ylglyoxylamides by modulation of translocator protein promoting neurosteroid biosynthesis 586
Totale 178.255
Salva come PNG Salva come JPEG
Categoria #
all - tutte 234.362
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 234.362
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216.003 0 0 0 0 0 0 0 0 0 2.491 1.964 1.548
2021/202210.467 1.147 719 656 770 740 687 720 604 759 1.075 1.110 1.480
2022/202317.432 1.649 2.449 1.978 1.467 1.488 1.707 837 1.260 1.134 1.264 1.513 686
2023/202415.716 713 740 548 865 1.643 2.554 2.484 1.094 709 1.113 1.602 1.651
2024/202523.526 4.557 4.795 3.957 3.215 1.708 1.964 2.040 165 355 273 309 188
2025/20267.806 776 356 893 658 729 539 1.830 543 499 983 0 0
Totale 187.444